Annual CFO
-$137.58 M
+$8.95 M+6.11%
December 31, 2023
Summary
- As of February 7, 2025, PHAT annual cash flow from operations is -$137.58 million, with the most recent change of +$8.95 million (+6.11%) on December 31, 2023.
- During the last 3 years, PHAT annual CFO has fallen by -$67.89 million (-97.42%).
- PHAT annual CFO is now -13348.68% below its all-time high of -$1.02 million, reached on December 31, 2018.
Performance
PHAT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$63.57 M
+$7.15 M+10.11%
September 30, 2024
Summary
- As of February 7, 2025, PHAT quarterly cash flow from operations is -$63.57 million, with the most recent change of +$7.15 million (+10.11%) on September 30, 2024.
- Over the past year, PHAT quarterly CFO has increased by +$7.15 million (+10.11%).
- PHAT quarterly CFO is now -7777.70% below its all-time high of -$807.00 thousand, reached on March 31, 2019.
Performance
PHAT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$247.11 M
-$31.66 M-14.69%
September 30, 2024
Summary
- As of February 7, 2025, PHAT TTM cash flow from operations is -$247.11 million, with the most recent change of -$31.66 million (-14.69%) on September 30, 2024.
- Over the past year, PHAT TTM CFO has dropped by -$31.66 million (-14.69%).
- PHAT TTM CFO is now -30520.94% below its all-time high of -$807.00 thousand, reached on March 31, 2019.
Performance
PHAT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PHAT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.1% | +10.1% | -14.7% |
| 3 y3 years | -97.4% | -54.9% | -68.6% |
| 5 y5 years | -10000.0% | -54.9% | -68.6% |
PHAT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.3% | -186.4% | +10.1% | -83.3% | at low |
| 5 y | 5-year | -276.8% | +7.3% | -580.4% | +10.1% | -576.8% | at low |
| alltime | all time | <-9999.0% | +7.3% | -7777.7% | +10.1% | <-9999.0% | at low |
Phathom Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$63.57 M(-10.1%) | -$247.11 M(+14.7%) |
| Jun 2024 | - | -$70.72 M(+2.5%) | -$215.45 M(+29.1%) |
| Mar 2024 | - | -$69.02 M(+57.6%) | -$166.93 M(+21.3%) |
| Dec 2023 | -$137.58 M(-6.1%) | -$43.80 M(+37.2%) | -$137.58 M(+2.0%) |
| Sep 2023 | - | -$31.91 M(+43.8%) | -$134.82 M(-2.2%) |
| Jun 2023 | - | -$22.20 M(-44.0%) | -$137.93 M(-2.5%) |
| Mar 2023 | - | -$39.67 M(-3.3%) | -$141.44 M(-3.5%) |
| Dec 2022 | -$146.53 M(-1.3%) | -$41.04 M(+17.2%) | -$146.53 M(-0.2%) |
| Sep 2022 | - | -$35.02 M(+36.2%) | -$146.75 M(+4.2%) |
| Jun 2022 | - | -$25.72 M(-42.5%) | -$140.80 M(-1.8%) |
| Mar 2022 | - | -$44.76 M(+8.5%) | -$143.45 M(-3.4%) |
| Dec 2021 | -$148.46 M | -$41.26 M(+42.0%) | -$148.46 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$29.07 M(+2.5%) | -$135.40 M(+6.6%) |
| Jun 2021 | - | -$28.36 M(-43.0%) | -$127.06 M(+17.6%) |
| Mar 2021 | - | -$49.77 M(+76.5%) | -$108.04 M(+55.0%) |
| Dec 2020 | -$69.69 M(+90.9%) | -$28.20 M(+36.1%) | -$69.69 M(+7.4%) |
| Sep 2020 | - | -$20.73 M(+121.8%) | -$64.87 M(+26.6%) |
| Jun 2020 | - | -$9.34 M(-18.2%) | -$51.25 M(+8.8%) |
| Mar 2020 | - | -$11.42 M(-51.2%) | -$47.12 M(+29.1%) |
| Dec 2019 | -$36.51 M(+3468.9%) | -$23.38 M(+229.0%) | -$36.51 M(+178.2%) |
| Sep 2019 | - | -$7.11 M(+36.4%) | -$13.13 M(+118.1%) |
| Jun 2019 | - | -$5.21 M(+545.7%) | -$6.02 M(+645.7%) |
| Mar 2019 | - | -$807.00 K | -$807.00 K |
| Dec 2018 | -$1.02 M | - | - |
FAQ
- What is Phathom Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual CFO year-on-year change?
- What is Phathom Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly CFO year-on-year change?
- What is Phathom Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM CFO year-on-year change?
What is Phathom Pharmaceuticals annual cash flow from operations?
The current annual CFO of PHAT is -$137.58 M
What is the all time high annual CFO for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual cash flow from operations is -$1.02 M
What is Phathom Pharmaceuticals annual CFO year-on-year change?
Over the past year, PHAT annual cash flow from operations has changed by +$8.95 M (+6.11%)
What is Phathom Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PHAT is -$63.57 M
What is the all time high quarterly CFO for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly cash flow from operations is -$807.00 K
What is Phathom Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PHAT quarterly cash flow from operations has changed by +$7.15 M (+10.11%)
What is Phathom Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PHAT is -$247.11 M
What is the all time high TTM CFO for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM cash flow from operations is -$807.00 K
What is Phathom Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PHAT TTM cash flow from operations has changed by -$31.66 M (-14.69%)